HRP20010529B1 - 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors - Google Patents

2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors

Info

Publication number: HRP20010529B1
Authority: HR; Croatia
Prior art keywords: monosaccharides; cell adhesion; adhesion inhibitors; isopropylidene derivatives; isopropylidene
Prior art date: 1999-01-15

Application number

HR20010529A

Other languages

English (en)

Inventor

K. Arora Sudershan

Kishore Nawal

Bahadur Gupta Jang

D. Joshi Vishwas

Original Assignee

Ranbaxy Laboratories Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-15

Filing date

2000-01-10

Publication date

2005-02-28

2000-01-10 Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited

2002-08-31 Publication of HRP20010529A2 publication Critical patent/HRP20010529A2/hr

2005-02-28 Publication of HRP20010529B1 publication Critical patent/HRP20010529B1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Neurology (AREA)
Diabetes (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Pulmonology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Rheumatology (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Dermatology (AREA)
Transplantation (AREA)
Obesity (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Surgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

HR20010529A 1999-01-15 2000-01-10 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors HRP20010529B1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IN86DE1999 IN190975B (xx)	1999-01-15	1999-01-15
US09/276,368 US6590085B1 (en)	1999-01-15	1999-03-25	Derivatives of monosaccharides as cell adhesion inhibitors
PCT/IB2000/000022 WO2000042054A1 (en)	1999-01-15	2000-01-10	2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors

Publications (2)

Publication Number	Publication Date
HRP20010529A2 HRP20010529A2 (en)	2002-08-31
HRP20010529B1 true HRP20010529B1 (en)	2005-02-28

Family

ID=11088155

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR20010529A HRP20010529B1 (en)	1999-01-15	2000-01-10	2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors

Country Status (30)

Country	Link
US (5)	US6590085B1 (xx)
EP (1)	EP1147119B1 (xx)
JP (1)	JP2002534530A (xx)
CN (1)	CN1167707C (xx)
AR (1)	AR022235A1 (xx)
AT (1)	ATE250074T1 (xx)
AU (1)	AU768511B2 (xx)
BG (1)	BG105745A (xx)
BR (1)	BR0007553A (xx)
CA (1)	CA2359986A1 (xx)
CO (1)	CO5180591A1 (xx)
CR (1)	CR6423A (xx)
CZ (1)	CZ20012540A3 (xx)
DE (1)	DE60005300T2 (xx)
DK (1)	DK1147119T3 (xx)
ES (1)	ES2206176T3 (xx)
HR (1)	HRP20010529B1 (xx)
HU (1)	HUP0105116A3 (xx)
ID (1)	ID30351A (xx)
IN (1)	IN190975B (xx)
MA (1)	MA25342A1 (xx)
MX (1)	MXPA01007187A (xx)
MY (1)	MY121135A (xx)
NZ (2)	NZ512852A (xx)
PA (1)	PA8489901A1 (xx)
PT (1)	PT1147119E (xx)
SK (1)	SK284241B6 (xx)
TR (1)	TR200102043T2 (xx)
WO (1)	WO2000042054A1 (xx)
YU (1)	YU50701A (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IN190975B (xx) *	1999-01-15	2003-09-06	Ranbaxy Lab Ltd
MXPA05012900A (es)	2003-05-30	2006-02-22	Ranbaxy Lab Ltd	Derivados de pirrol sustituidos.
WO2006024926A1 (en) *	2004-09-02	2006-03-09	Ranbaxy Laboratories Limited	Monosaccharide derivatives
JP2008525421A (ja) *	2004-12-22	2008-07-17	ランバクシーラボラトリーズリミテッド	モノサッカリド誘導体
US20090054519A1 (en) *	2005-07-22	2009-02-26	Abhijit Ray	Derivatives of monosaccharides as 5-lipoxygenase inhibitors
CA2627599A1 (en) *	2005-11-08	2007-05-18	Ranbaxy Laboratories Limited	Process for (3r,5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino)carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
CL2007000667A1 (es) *	2006-03-14	2008-03-14	Ranbaxi Lab Ltd	Composicion farmaceutica que comprende al acido 7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]pirrol-1-il]-3,5-dihidroxi-heptanoico o una sal y al menos un agente estabilizante; procedimiento de preparacion, util en e
US20080114031A1 (en) *	2006-03-29	2008-05-15	Sattigeri Viswajanani J	Monosaccharide derivatives
EP1864992A2 (en) *	2006-05-30	2007-12-12	Ranbaxy Laboratories, Ltd.	Monosaccharide derivatives
EP1953170A1 (en) *	2006-10-03	2008-08-06	Ranbaxy Laboratories Limited	Monosaccharide derivatives as anti-inflammatory agents
AU2008221506B2 (en) *	2007-09-20	2011-01-20	ResMed Pty Ltd	Retractable Tube for CPAP

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2715121A (en)	1950-09-09	1955-08-09	American Home Prod	Alkyl sugar derivatives and their preparation
US4056322A (en)	1973-12-14	1977-11-01	Strategic Medical Research Corporation	Preparation of ethers of monosaccharides
US4735934A (en)	1981-02-17	1988-04-05	Greenwich Pharmaceuticals Incorporated	Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease
US4996195A (en)	1989-01-09	1991-02-26	Greenwich Pharmaceuticals Inc.	Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives
US5010058A (en)	1989-06-22	1991-04-23	501 Greenwich Pharmaceuticals Incorporated	3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives
FR2652540B1 (fr)	1989-10-02	1995-06-02	Imaje Sa	Circuit d'encre notamment destine a la mise en pression d'une encre a pigments pour imprimante a jet d'encre.
US5192746A (en)	1990-07-09	1993-03-09	Tanabe Seiyaku Co., Ltd.	Cyclic cell adhesion modulation compounds
US5258402A (en)	1992-06-11	1993-11-02	Mcneil-Ppc, Inc.	Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates
US5432163A (en)	1992-11-13	1995-07-11	Greenwich Pharmaceuticals Incorporated	Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides
US5637570A (en) *	1995-05-09	1997-06-10	Chemora Pharmochem	Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity
IN190975B (xx) *	1999-01-15	2003-09-06	Ranbaxy Lab Ltd

1999
- 1999-01-15 IN IN86DE1999 patent/IN190975B/en unknown
- 1999-03-25 US US09/276,368 patent/US6590085B1/en not_active Expired - Fee Related
2000
- 2000-01-10 YU YU50701A patent/YU50701A/sh unknown
- 2000-01-10 AT AT00900088T patent/ATE250074T1/de not_active IP Right Cessation
- 2000-01-10 BR BR0007553-1A patent/BR0007553A/pt not_active IP Right Cessation
- 2000-01-10 CZ CZ20012540A patent/CZ20012540A3/cs unknown
- 2000-01-10 NZ NZ512852A patent/NZ512852A/xx unknown
- 2000-01-10 DE DE60005300T patent/DE60005300T2/de not_active Expired - Fee Related
- 2000-01-10 CA CA002359986A patent/CA2359986A1/en not_active Abandoned
- 2000-01-10 PT PT00900088T patent/PT1147119E/pt unknown
- 2000-01-10 JP JP2000593621A patent/JP2002534530A/ja active Pending
- 2000-01-10 EP EP00900088A patent/EP1147119B1/en not_active Expired - Lifetime
- 2000-01-10 MX MXPA01007187A patent/MXPA01007187A/es not_active IP Right Cessation
- 2000-01-10 ID IDW00200101520A patent/ID30351A/id unknown
- 2000-01-10 DK DK00900088T patent/DK1147119T3/da active
- 2000-01-10 HR HR20010529A patent/HRP20010529B1/xx not_active IP Right Cessation
- 2000-01-10 HU HU0105116A patent/HUP0105116A3/hu unknown
- 2000-01-10 WO PCT/IB2000/000022 patent/WO2000042054A1/en active IP Right Grant
- 2000-01-10 ES ES00900088T patent/ES2206176T3/es not_active Expired - Lifetime
- 2000-01-10 TR TR2001/02043T patent/TR200102043T2/xx unknown
- 2000-01-10 AR ARP000100086A patent/AR022235A1/es not_active Application Discontinuation
- 2000-01-10 CN CNB008048525A patent/CN1167707C/zh not_active Expired - Fee Related
- 2000-01-10 NZ NZ527483A patent/NZ527483A/en unknown
- 2000-01-10 AU AU18861/00A patent/AU768511B2/en not_active Ceased
- 2000-01-10 SK SK10132001A patent/SK284241B6/sk unknown
- 2000-01-14 PA PA20008489901A patent/PA8489901A1/es unknown
- 2000-01-14 CO CO00001575A patent/CO5180591A1/es not_active Application Discontinuation
- 2000-01-14 MY MYPI20000121A patent/MY121135A/en unknown
2001
- 2001-07-12 MA MA26266A patent/MA25342A1/fr unknown
- 2001-07-12 CR CR6423A patent/CR6423A/xx not_active Application Discontinuation
- 2001-07-26 BG BG105745A patent/BG105745A/xx unknown
2003
- 2003-07-01 US US10/611,093 patent/US7005422B2/en not_active Expired - Fee Related
- 2003-07-01 US US10/611,386 patent/US7005516B2/en not_active Expired - Fee Related
- 2003-07-01 US US10/611,091 patent/US20040018995A1/en not_active Abandoned
- 2003-07-01 US US10/610,719 patent/US7037899B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1147119B1 (en)	2003-09-17
CA2359986A1 (en)	2000-07-20
HRP20010529A2 (en)	2002-08-31
IN190975B (xx)	2003-09-06
AU768511B2 (en)	2003-12-18
MXPA01007187A (es)	2002-04-24
PA8489901A1 (es)	2000-09-29
ES2206176T3 (es)	2004-05-16
NZ527483A (en)	2005-02-25
ATE250074T1 (de)	2003-10-15
YU50701A (sh)	2005-06-10
US7005516B2 (en)	2006-02-28
US20040018995A1 (en)	2004-01-29
AR022235A1 (es)	2002-09-04
CO5180591A1 (es)	2002-07-30
SK284241B6 (en)	2004-11-03
DE60005300D1 (de)	2003-10-23
TR200102043T2 (tr)	2001-11-21
DK1147119T3 (da)	2004-01-19
SK10132001A3 (sk)	2002-01-07
US20040029820A1 (en)	2004-02-12
HK1041270A1 (en)	2002-07-05
JP2002534530A (ja)	2002-10-15
BR0007553A (pt)	2001-12-18
US20040019191A1 (en)	2004-01-29
CR6423A (xx)	2004-03-09
MA25342A1 (fr)	2001-12-31
DE60005300T2 (de)	2004-07-15
BG105745A (en)	2002-05-31
HUP0105116A3 (en)	2003-05-28
MY121135A (en)	2005-12-30
US7037899B2 (en)	2006-05-02
CN1167707C (zh)	2004-09-22
HUP0105116A2 (hu)	2003-04-28
US6590085B1 (en)	2003-07-08
PT1147119E (pt)	2004-02-27
AU1886100A (en)	2000-08-01
CN1343213A (zh)	2002-04-03
US7005422B2 (en)	2006-02-28
EP1147119A1 (en)	2001-10-24
US20040023900A1 (en)	2004-02-05
CZ20012540A3 (cs)	2002-02-13
WO2000042054A1 (en)	2000-07-20
ID30351A (id)	2001-11-22
NZ512852A (en)	2004-02-27

Publication	Publication Date	Title
AU6903200A (en)	2001-03-13	Heterocycle amides as cell adhesion inhibitors
AU5152100A (en)	2000-12-12	Substituted beta-alanine derivatives as cell adhesion inhibitors
EP1001764A4 (en)	2005-08-24	Heterocyclic amides as cell adhesion inhibitors
AU8059598A (en)	1999-12-30	Heterocyclic amide compounds as cell adhesion inhibitors
IL149651A0 (en)	2002-11-10	N6 heterocyclic 8-modified adenosine derivatives
ZA95937B (en)	1996-08-06	Sulfated alpha-glycolipid derivatives as cell adhesion inhibitors
HUP0202450A3 (en)	2003-12-29	N-heterocyclic derivatives as nos inhibitors
AU1463499A (en)	1999-06-15	Substituted pyrrole derivatives as cell adhesion inhibitors
EP0998282A4 (en)	2000-08-30	SULFAMIDES FOR USE AS CELL ADHESION INHIBITORS
AU6909300A (en)	2001-03-19	Substituted ureas as cell adhesion inhibitors
PL364926A1 (en)	2004-12-27	Heterocyclic dihydropyrimidines as potassium channel inhibitors
IL144274A0 (en)	2002-05-23	Derivatives of monosaccharides as cell adhesion inhibitors
PL355099A1 (en)	2004-04-05	Pyrrole derivatives as phosphodiesterase vii inhibitors
AU4170200A (en)	2000-09-21	Improved water purification pack
PL355022A1 (en)	2004-03-22	Imidazopyridine derivatives as phosphodiesterase vii inhibitors
PL352296A1 (en)	2003-08-11	Crystalline derivatives of 1-methylocarbapeneme
GB0017279D0 (en)	2000-08-30	Amides as cell adhesion inhibitors
HRP20010529B1 (en)	2005-02-28	2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors
AU2690600A (en)	2000-09-14	2-mercaptocarboxylic acid derivatives
HUP0300183A3 (en)	2005-12-28	Substituted purine derivatives as inhibitors of cell adhesion
EP1389200A4 (en)	2007-03-28	SUBSTITUTED N-ARYLSULFONYL-PROLINE DERIVATIVES AS POWERFUL INHIBITORS OF CELL ADHESION
PL355020A1 (en)	2004-03-22	Imidazole derivatives as phosphodiesterase vii inhibitors
AU1303201A (en)	2001-06-06	Alkoxyiminoalkanoic acid derivatives
IL112734A0 (en)	1995-05-26	Sulfated beta-glycolipid derivatives as cell adhesion inhibitors
IL144273A0 (en)	2002-05-23	2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors

Legal Events

Date	Code	Title	Description
2002-08-31	A1OB	Publication of a patent application
2003-02-26	AIPI	Request for the grant of a patent on the basis of a substantive examination of a patent application
2005-02-28	B1PR	Patent granted
2006-01-10	ODRP	Renewal fee for the maintenance of a patent	Payment date: 20060110 Year of fee payment: 7
2007-07-11	PBON	Lapse due to non-payment of renewal fee	Effective date: 20070111